Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
112.45
108.74
92.44
112.27
85.97
85.97
77.99
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
112.45
108.74
92.44
112.27
85.97
85.97
77.99
Raw Material Cost
70.72
62.88
54.67
63.42
49.48
49.48
46.46
Purchase of Finished goods
0.93
5.80
1.22
5.82
1.94
1.94
0.85
(Increase) / Decrease In Stocks
-1.45
-0.64
1.27
0.53
-0.42
-0.42
1.53
Employee Cost
14.39
13.29
12.17
11.93
11.82
11.82
12.04
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.27
6.56
6.02
6.32
4.27
4.27
4.25
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
16.84
12.75
9.53
13.56
15.53
15.53
11.93
Total Expenditure (Excl Depreciation)
107.70
100.64
84.88
101.58
82.62
82.62
77.06
Operating Profit (PBDIT) excl Other Income
4.75
8.10
7.56
10.69
3.35
3.35
0.93
Other Income
23.35
14.89
9.93
10.78
2.91
2.91
5.30
Operating Profit (PBDIT)
28.10
22.99
17.49
21.47
6.26
6.26
6.23
Interest
0.23
0.36
0.22
0.24
0.20
0.20
0.57
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
27.87
22.63
17.27
21.23
6.06
6.06
5.66
Depreciation
2.20
1.95
1.33
1.66
3.16
3.16
3.12
Profit Before Tax
25.67
20.68
15.94
19.56
2.91
2.91
2.54
Tax
6.16
3.91
3.31
5.47
1.05
1.05
1.61
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
19.50
16.78
12.63
14.09
1.85
1.85
0.93
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
19.50
16.78
12.63
14.09
1.85
1.85
0.93
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
19.50
16.78
12.63
14.09
1.85
1.85
0.93
Equity Capital
21.04
21.04
21.04
21.04
21.04
21.04
21.04
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
150.39
130.87
113.54
100.69
86.60
79.33
77.24
Earnings per share (EPS)
9.27
7.98
6.0
6.7
0.88
0.88
0.44
Diluted Earnings per share
9.34
8.01
5.9
6.67
0.89
0.89
0.41
Operating Profit Margin (Excl OI)
4.22%
7.45%
8.18%
9.52%
3.9%
3.9%
1.19%
Gross Profit Margin
24.78%
20.81%
18.68%
18.91%
7.05%
7.05%
7.26%
PAT Margin
17.34%
15.43%
13.66%
12.55%
2.15%
2.15%
1.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 3.41% vs 17.63% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 16.21% vs 32.86% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -41.36% vs 7.14% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -36.11% vs 63.64% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Alpa Laboratorie With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
112.45
292.56
-180.11
-61.56%
Other Operating Income
0.00
0.00
0.00
Total Operating income
112.45
292.56
-180.11
-61.56%
Raw Material Cost
70.72
165.70
-94.98
-57.32%
Purchase of Finished goods
0.93
0.00
0.93
(Increase) / Decrease In Stocks
-1.45
0.00
-1.45
Employee Cost
14.39
34.74
-20.35
-58.58%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
6.27
0.00
6.27
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
16.84
54.91
-38.07
-69.33%
Total Expenditure (Excl Depreciation)
107.70
255.35
-147.65
-57.82%
Operating Profit (PBDIT) excl Other Income
4.75
37.21
-32.46
-87.23%
Other Income
23.35
-3.72
27.07
727.69%
Operating Profit (PBDIT)
28.10
33.49
-5.39
-16.09%
Interest
0.23
2.93
-2.70
-92.15%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
27.87
30.56
-2.69
-8.80%
Depreciation
2.20
1.89
0.31
16.40%
Profit Before Tax
25.67
28.67
-3.00
-10.46%
Tax
6.16
3.60
2.56
71.11%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
19.50
25.07
-5.57
-22.22%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
19.50
25.07
-5.57
-22.22%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
19.50
25.07
-5.57
-22.22%
Equity Capital
21.04
11.04
10.00
90.58%
Face Value
10.00
2.00
0.00
Reserves
150.39
220.69
-70.30
-31.85%
Earnings per share (EPS)
9.27
4.54
4.73
104.19%
Diluted Earnings per share
9.34
4.54
4.80
105.73%
Operating Profit Margin (Excl OI)
4.22%
12.72%
0.00
-8.50%
Gross Profit Margin
24.78%
10.45%
0.00
14.33%
PAT Margin
17.34%
8.57%
0.00
8.77%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 112.45 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.41% vs 17.63% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 19.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.21% vs 32.86% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.75 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -41.36% vs 7.14% in Mar 2024
Annual - Interest
Interest 0.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -36.11% vs 63.64% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.22%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024






